Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted
China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Proposed combination enhances Pfizer’s position as a leading company in oncology
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Subscribe To Our Newsletter & Stay Updated
